J&J Seeks Oral, Skin And Hair 'Game Changers' Via Research Collaborations
This article was originally published in The Rose Sheet
Executive Summary
Consumer innovation collaborations with external partners aim to shed light on oral biofilm disruption, the skin microbiome's influence on skin health and androgenetic alopecia (hair loss). Announced deals include early-stage discovery or pre-clinical partnerships with academia or biotechs facilitated by J&J’s Innovation Centers in the US, UK and China.
You may also be interested in...
Jurors' Answers In FTC's Prevagen Complaint Might Burst A Memory Bubble For Health Claims
“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put a fork in the road of a long dispute between FTC and supplement product manufacturers and marketers.
MLM Group Not Buying FTC Executive’s Concerns About Its Income Disclosure Guidance
FTC Division of Marketing Practices assistant director concerned direct selling self-regulation group’s guidance “will encourage deceptive conduct and facilitate deceptive earnings claims.” DSA president says the concerns might reflect the thinking of agency’s staff more than the intent of the agency’s regulations.
With Winrevair Approved, Merck Has A Chance To Execute On CV Strategy
The activin signaling inhibitor sotatercept was approved by the US FDA for pulmonary arterial hypertension.